Victory Capital Management
XLRN

Victory Capital Management’s Acceleron Pharma XLRN Stock Holding History

Victory Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,309
Closed -$1.26M – 2899
2021
Q3 		$1.26M Buy
7,309
+231
+3% +$30.2K ﹤0.01% 1758
2021
Q2 		$888K Sell
7,078
-2,347
-25% -$296K ﹤0.01% 1939
2021
Q1 		$1.28M Sell
9,425
-2,714
-22% -$351K ﹤0.01% 1801
2020
Q4 		$1.55M Buy
12,139
+1,047
+9% +$123K ﹤0.01% 1599
2020
Q3 		$1.25M Buy
11,092
+1,572
+17% +$156K ﹤0.01% 1610
2020
Q2 		$907K Sell
9,520
-5,770
-38% -$556K ﹤0.01% 1773
2020
Q1 		$1.37M Buy
15,290
+7,926
+108% +$616K ﹤0.01% 1741
2019
Q4 		$390K Buy
7,364
+1,672
+29% +$76.2K ﹤0.01% 2114
2019
Q3 		$225K Buy
+5,692
New +$247K ﹤0.01% 2183

Victory Capital Management's XLRN Position: Q4 2021 in Review

Victory Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 7,309 shares — an estimated $1.26M sold.

Victory Capital Management first reported a position in XLRN in Q3 2019 and held it in 9 quarters. The position peaked at $1.55M in Q4 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Victory Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Victory Capital Management sold 7,309 Acceleron Pharma shares in Q4 2021, an estimated $1.26M.
  • Victory Capital Management first reported a position in Acceleron Pharma in Q3 2019 and held it in 9 quarters.
  • Victory Capital Management's Acceleron Pharma position peaked at $1.55M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.